Growth Metrics

Merck (MRK) Depreciation & Amortization (CF) (2016 - 2025)

Merck (MRK) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 177.39% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, up 26.21% year-over-year, with the annual reading at $3.0 billion for FY2025, 42.59% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $1.4 billion at Merck, up from $449.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.4 billion in Q4 2025, with the low at $62.0 million in Q2 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $466.8 million, with a median of $448.0 million recorded in 2022.
  • Peak annual rise in Depreciation & Amortization (CF) hit 177.39% in 2025, while the deepest fall reached 86.22% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $452.0 million in 2021, then decreased by 10.18% to $406.0 million in 2022, then increased by 16.75% to $474.0 million in 2023, then rose by 10.13% to $522.0 million in 2024, then soared by 177.39% to $1.4 billion in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $1.4 billion, $449.0 million, and $62.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.